you're reading...
BLOG, Economic and Social Policies, PUBLICATIONS

Health and technology in life sciences

We are seeing developments in biotechnology that seem futuristic, such as computing systems at clinical testing stages used as ‘sensitive interaction partners’ for the elderly that help to provide care in response to individual needs. Such developments raise a range of questions. To what extent should humans use technology to enhance life? And how can these technologies be governed to uphold social, ethical and legal standards?

Over the past 5 years, STOA has been involved in work about the health and life sciences, examining how to improve our understanding of health and disease, the state of research infrastructures in the life sciences, and the role technology can play in these areas. STOA is the Science and Technology Options Assessment body,which provides independent scientific advice to the European Parliament.

STOA’s 2012 study, ‘Making perfect life’, focused on the convergence of nanotechnology, biotechnology, information technology, and cognitive sciences, identifying two ‘megatrends’ as these fields are brought together. On the one hand, biology is becoming technology: as scientists look at living organisms in mechanical terms, they are using engineering and technology to intervene in life. On the other, technology is becoming biology: insights from the life sciences are inspiring engineering and scientists are creating lifelike artificial objects. An example of this convergence is deep brain stimulation. Electrodes can be implanted deep in the brain to alter brain activity. This can treat the tremor symptoms of Parkinson’s disease, but requires surgery and can have serious physical and psychological side effects, such as infection or changes in perception.

The study recommended, first, a broader bioethics debate that went beyond the life sciences to include nanotechnology, biotechnology, information technology, and the cognitive sciences. Second, it recommended forward-looking biopolitics, to ensure that new and changing practices were monitored and regulated.

In a workshop on 26 April 2012, entitled ‘Human Enhancement – The ethical issues’, STOA held a bioethical discussion related to biotechnology used in humans. The workshop discussed the findings of the studies on ‘Human Enhancement’ (2009) and ‘Making Perfect Life’ with representatives from major religious communities. Those present agreed that humans should not simply be seen as biological machines. But views were more diverse on the subject of how far medicine should go: from the Orthodox position that treating pain could be seen as inappropriate, to the idea that science and research were a duty in Judaism.

Alongside this work on biotechnology, STOA has focused on health issues, particularly on the future direction of research in the life sciences and the associated need for improved collaboration between scientists and policy-makers to meet healthcare challenges.

Many patients feel that the most significant impact of a mental or neurological condition is the societal stigma attached, rather than the effects of their disease. This response arose from the STOA workshop on 23 April 2013, which asked, ‘What does it mean to have a brain disorder?’. The workshop also emphasised the burden on the elderly and the lack of attention paid to children affected by brain disorders. These conclusions were reaffirmed in a letter to the editor of The Lancet Neurology in June 2013.

Digestive and liver diseases lack public and political attention. This was the reason behind a STOA workshop, ‘Research on Digestive and Liver Diseases: a Priority for Europe’, held on 18 September 2012 in collaboration with United European Gastroenterology. The conclusions were published in the European Journal of Gastroenterology & Hepatology in August 2013. Gastrointestinal and liver tumours make up about 30% of total EU cancer deaths. Gastrointestinal diseases are the cause of more than a third of acute hospital admissions. Co-ordination of research at a European level and sufficient funding are essential. However, action is impeded by the barriers between scientists and policy-makers, who have different mentalities and speak different languages. STOA’s work seeks to help remove these obstacles between the worlds of science and policy.


Study-related workshops

Ad hoc events

List of publications

Quaglio GL, Karapiperis T, Van Woensel L, Arnold E, McDaid D.

McDaid D, Quaglio GL, Correia de Campos A, Dario C, Van Woensel L, Karapiperis T, Reeves A.

Quaglio GL, Karapiperis T, Di Luca M, de Campos AC, Dan B.

Stockbrugger R, Quaglio GL, O’Morain C, Rubig P, Manns M.

Quaglio GL, Demotes-Mainard J, Loddenkemper R.

About Scientific Foresight (STOA)

The Scientific Foresight Unit (STOA) carries out interdisciplinary research and provides strategic advice in the field of science and technology options assessment and scientific foresight. It undertakes in-depth studies and organises workshops on developments in these fields, and it hosts the European Science-Media Hub (ESMH), a platform to promote networking, training and knowledge sharing between the EP, the scientific community and the media. All this work is carried out under the guidance of the Panel for the Future of Science and Technology (STOA), composed of 27 MEPs nominated by 11 EP Committees. The STOA Panel forms an integral part of the structure of the EP.


No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,510 other followers

RSS Link to Scientific Foresight (STOA)

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.

%d bloggers like this: